Showing results (371-380 of 503) with videos related to

Sort By:
Pageof 51
Atherosclerosis|March 20, 2012
Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolBrian H Shirts, Michael T Howard, Sandra J Hasstedt, et al.
Diabetes Care|May 20, 2008
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMIAnita Brandstätter, Stefan Kiechl, Barbara Kollerits, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Different polymorphisms of the mineralocorticoid receptor gene are associated with either glucocorticoid or mineralocorticoid levels in hypertensionBei Sun, Bindu Chamarthi, Jonathan S Williams, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1990
Genetics of hypertension: what we know and don't knowR R Williams, S C Hunt, S J Hasstedt, et al.
Hypertension (Dallas, Tex. : 1979)|October 8, 2003
Genetic determinants of nonmodulating hypertensionNatapong Kosachunhanun, Steven C Hunt, Paul N Hopkins, et al.
Diabetes|April 29, 2006
The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetesVeit Schoenborn, Iris M Heid, Caren Vollmert, et al.
Journal of Lipid Research|July 1, 1997
Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteinsE H Ludwig, P N Hopkins, A Allen, et al.
The American Journal of Cardiology|May 27, 2006
Association of coronary artery calcified plaque with clinical coronary heart disease in the National Heart, Lung, and Blood Institute's Family Heart StudyPaul N Hopkins, R Curtis Ellison, Michael A Province, et al.
BMC Cardiovascular Disorders|October 30, 2007
Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart StudyWeihong Tang, James S Pankow, J Jeffrey Carr, et al.
Lipids in Health and Disease|October 20, 2011
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional studyMary K Wojczynski, Stephen P Glasser, Albert Oberman, et al.
Pageof 51